Oxford Asset Management’s Teladoc Health TDOC Stock Holding History

Oxford Asset Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-28,559	Closed	-$200K	–	729
2025 Q4	$200K	Buy	+28,559	New	+$224K	0.07%	387

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oxford Asset Management's TDOC Position: Q1 2026 in Review

Oxford Asset Management sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 28,559 shares — an estimated $200K sold.

Oxford Asset Management first reported a position in TDOC in Q4 2025 and held it in 1 quarter. The position peaked at $200K in Q4 2025. 325 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

Oxford Asset Management reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
Oxford Asset Management sold 28,559 Teladoc Health shares in Q1 2026, an estimated $200K.
Oxford Asset Management first reported a position in Teladoc Health in Q4 2025 and held it in 1 quarter.
Oxford Asset Management's Teladoc Health position peaked at $200K in Q4 2025.
325 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Oxford Asset Management's 13F filing for Q1 2026, filed 15 May 2026.